Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
Bagsværd, Denmark, 17 January 2025 – Novo Nordisk today announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a 72-week efficacy and safety trial invest
7 A-Rated Dividend Aristocrat Bargains With Big Upside Potential In 2025
07:00am, Friday, 17'th Jan 2025
Seven Dividend Aristocrats are trading at 52-week lows, but if they return to their historical fair value, they could offer a 34% upside potential in 2025. These aristocrats have strong fundamentals,
Novo Holdings looks to double Catalent size with eye on Trump US manufacturing focus
02:24pm, Thursday, 16'th Jan 2025
Novo Holdings, the controlling shareholder of Novo Nordisk , hopes to double the size of its recently acquired contract drugmaker Catalent over five years, a senior partner at the investment firm said
Finally An Attractive Entry Point Into Novo Nordisk
07:56am, Thursday, 16'th Jan 2025
Finally An Attractive Entry Point Into Novo Nordisk
NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow Down
02:31pm, Wednesday, 15'th Jan 2025
Shares of several obesity drugmakers dip after LLY lowered its revenue outlook for 2024 amid slower-than-expected sales growth of its tirzepatide products in Q4.
Novo Nordisk: Excellent Opportunity To Buy The Dip
07:42am, Wednesday, 15'th Jan 2025
Novo Nordisk presents a compelling 'Strong Buy' opportunity with a 51% upside potential. NVO's financial strength is evident through its 74% historical average ROIC, 85% gross margin, and substantial
Novo-Nordisk Stock (NVO) Could Be Longer-Term Turnaround Play
09:49pm, Tuesday, 14'th Jan 2025
Obesity is rising and in the last 35 years, has more than doubled. The world population in 1999 to today is 42% or 22 million adults with a body mass index of 40 or higher.
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday
12:11pm, Tuesday, 14'th Jan 2025
Bad news for Eli Lilly (LLY -7.38%) stock dragged down shares of rival companies in the market for GLP-1 diet drugs on Tuesday. Lilly updated investors on its expected revenue for 2024 this morning, a
Novo Nordisk excitement starts to build ahead of February results
05:56am, Tuesday, 14'th Jan 2025
Novo Nordisk (NYSE:NVO) fourth-quarter results on February 5, 2025, will be a big announcement for Europe's largest company given the febrile excitement surrounding its blockbuster appetite-reducing /
Novo Nordisk (NVO) Stock Slides as Market Rises: Facts to Know Before You Trade
06:51pm, Monday, 13'th Jan 2025
In the most recent trading session, Novo Nordisk (NVO) closed at $84.62, indicating a -1.9% shift from the previous trading day.
Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know
10:11am, Monday, 13'th Jan 2025
Zacks.com users have recently been watching Novo Nordisk (NVO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
How I Would Invest Today Half A Million To Live Off Dividends
10:00am, Monday, 13'th Jan 2025
I aim to create a $500,000 portfolio for passive income, focusing on high-yield and growth companies to outpace inflation. My portfolio includes 10 companies: 70% stable high-yielders like Pepsi, BTI,
Novo Nordisk A/S - share repurchase programme
08:52am, Monday, 13'th Jan 2025
Bagsværd, Denmark, 13 January 2025 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and C
4 Top Dividend Growth Stocks to Build Your Portfolio Around in 2025
09:00am, Friday, 10'th Jan 2025
You will want to build your portfolio the right way if you're going to make money with stocks over the long haul. You wouldn't build your house on a shaky foundation, would you?
Eli Lilly (LLY) Vs Novo Nordisk (NVO): Which is the Best Weight Loss Stock for 2025?
08:41pm, Thursday, 09'th Jan 2025
Weight loss goals may be at the forefront of many New Year's resolutions, which could push the exuberance for Eli Lilly (LLY) and Novo Nordisk (NVO) stock.
